EGFR and cancer: Signaling through EGFR (ErbB1) and its family members ErbB2 (Her2/Neu2) ErbB3 and ErbB4 regulates cellular processes such as survival, proliferation, differentiation and motility and ErbB receptors are important targets for new and existing anti-cancer drugs [1],[2].